Literature DB >> 11371508

hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay.

S A Pitts1, H S Kullar, T Stankovic, G S Stewart, J I Last, T Bedenham, S J Armstrong, M Piane, L Chessa, A M Taylor, P J Byrd.   

Abstract

We showed recently that mutation of the hMRE11 gene identified a new ataxia telangiectasia-like disorder (ATLD). In this report we describe the genomic organization of the hMRE11 gene and the analysis of a promoter region that appears to direct the divergent transcription of hMRE11 and the adjacent gene. The characterization of the genomic organization of the hMRE11 gene allowed us to determine the basis of an apparent null hMRE11 allele present in the mother and two patients in one of our two ATLD families. Polymorphic markers in the hMRE11 gene, including the promoter region, provided evidence that the mutated maternal allele was not deleted. An exon by exon search revealed the presence of a missense mutation in exon 15, the effect of which was to create a premature termination codon. Transcripts derived from the mutant allele were found to be subject to nonsense-mediated mRNA decay (NMD). Therefore, this allele was effectively null, because little if any mRNA from it was available for translation. The ATLD patients carrying this protein-truncating hMRE11 mutation have survived because the null allele they inherited from their mother is present with a missense mutation inherited from their father, which is expressed as normal levels of partially functional MRE11 protein. The mutation in the maternal hMRE11 allele of family 2 was also identified in a further unrelated Italian family with ATLD and also found to be subject to NMD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371508     DOI: 10.1093/hmg/10.11.1155

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  20 in total

1.  Homozygous hereditary C3 deficiency due to a premature stop codon.

Authors:  Edimara Da Silva Reis; Gisele Vanessa Baracho; Adriana Sousa Lima; Chuck S Farah; Lourdes Isaac
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

Review 2.  Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis.

Authors:  Lawrence B Gardner
Journal:  Mol Cancer Res       Date:  2010-02-23       Impact factor: 5.852

3.  Generating SM(a)RTer compounds for translation termination suppression in A-T and other genetic disorders.

Authors:  Martin F Lavin
Journal:  Mol Ther       Date:  2013-09       Impact factor: 11.454

Review 4.  Structural studies of DNA end detection and resection in homologous recombination.

Authors:  Christian Bernd Schiller; Florian Ulrich Seifert; Christian Linke-Winnebeck; Karl-Peter Hopfner
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-07-31       Impact factor: 10.005

Review 5.  Molecular pathology of ataxia telangiectasia.

Authors:  A M R Taylor; P J Byrd
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 6.  Ataxia-telangiectasia and related diseases.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

7.  Expression of mutant JAGGED1 alleles in patients with Alagille syndrome.

Authors:  Julie Boyer; Cécile Crosnier; Catherine Driancourt; Nicole Raynaud; Marie Gonzales; Michelle Hadchouel; Michèle Meunier-Rotival
Journal:  Hum Genet       Date:  2005-03-17       Impact factor: 4.132

8.  A glycine-arginine domain in control of the human MRE11 DNA repair protein.

Authors:  Ugo Déry; Yan Coulombe; Amélie Rodrigue; Andrzej Stasiak; Stéphane Richard; Jean-Yves Masson
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

9.  Bisbenzamidine derivative, pentamidine represses DNA damage response through inhibition of histone H2A acetylation.

Authors:  Junya Kobayashi; Akihiro Kato; Yosuke Ota; Reiko Ohba; Kenshi Komatsu
Journal:  Mol Cancer       Date:  2010-02-09       Impact factor: 27.401

10.  Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.

Authors:  Saeed A Bohlega; Jameela M Shinwari; Latifa J Al Sharif; Dania S Khalil; Thamer S Alkhairallah; Nada A Al Tassan
Journal:  BMC Med Genet       Date:  2011-02-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.